Olverembatinib dimesylate
Olverembatinib dimesylate (GZD824 Dimesylate) is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
| Catalog Number | T2429 |
| Alternative Name(s) | GZD824 Dimesylate , HQP1351 |
| Research Area | Angiogenesis|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors |
| Molecular Formula | C29H27F3N6O·2CH4O3S |
| CAS# | 1421783-64-3 |
| Purity | 99.81% |
| SMILES | CS(=O)(=O)O.CS(=O)(=O)O.CN1CCN(Cc2c(cc(NC(=O)c3cc(C#Cc4cc5c([nH]nc5)nc4)c(C)cc3)cc2)C(F)(F)F)CC1 |
| Size | 2 mg |
| Supplier Page | https://www.targetmol.com/compound/Olverembatinib dimesylate |
| Additional Information | https://www.targetmol.com/datasheet/T2429 |